Filter
1341
Filtered Results: 1341
Text search:
co-morbidities
Featured
Recommendations
149
New Publications
236
Language
Document type
No document type
556
Guidelines
307
Studies & Reports
262
Strategic & Response Plan
64
Manuals
63
Fact sheets
46
Situation Updates
16
Training Material
13
Infographics
8
Resource Platforms
4
Brochures
1
Online Courses
1
Countries / Regions
Global
89
India
80
South Africa
43
Kenya
38
Latin America and the Carribbean
38
Western and Central Europe
32
Africa
26
Ethiopia
23
Nigeria
20
Bangladesh
18
Eastern Europe
17
Brazil
17
Uganda
15
Ghana
14
South–East Asia Region
14
Ukraine
12
Rwanda
12
Tanzania
12
Nepal
11
Philippines
10
East and Southern Africa
10
Myanmar / Burma
10
Sierra Leone
9
Syria
9
Malawi
9
Asia
9
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Namibia
9
Zambia
9
Senegal
8
Congo, Democratic Republic of
8
Russia
8
Indonesia
8
Zimbabwe
7
Eswatini/ Swaziland
6
Cameroon
5
Burkina Faso
5
Peru
5
Mozambique
5
Western Pacific Region
5
South Sudan
5
Colombia
4
Chile
4
Eastern Europe and Central Asia
4
United Kingdom
4
Liberia
4
Lesotho
3
Cambodia
3
Vietnam
3
Georgia
3
Angola
3
Pakistan
3
Tajikistan
2
Turkey
2
Benin
2
Togo
2
Laos
2
Guinea
2
Venezuela
2
North America
2
Portugal
2
Bolivia
2
Argentina
2
Egypt
2
Botswana
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Mexico
1
Gambia
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
USA
1
Haiti
1
Guinea-Bissau
1
Paraguay
1
Gabon
1
Jamaica
1
France
1
Mauritius
1
Spain
1
Algeria
1
Moldova
1
Romania
1
Central African Republic
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
485
Clinical Guidelines
166
Public Health
97
Women & Child Health
31
Key Resources
16
Capacity Building
10
Pharmacy & Technologies
1
Toolboxes
COVID-19
280
TB
159
HIV
142
Mental Health
122
NCDs
83
NTDs
41
Caregiver
36
AMR
30
Disability
23
Rapid Response
21
Pharmacy
17
Conflict
17
Refugee
14
Planetary Health
10
Health Financing Toolbox
8
Cholera
7
Ebola & Marburg
7
Global Health Education
6
Natural Hazards
3
Polio
3
Zika
2
Specific Hazards
1
Social Ethics
1
Malaria
1
BMJ Global Health2020;5:e002014. doi:10.1136/bmjgh-2019-002014
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
Epilepsy is one of the world’s most common chronic neurological disorders. Roughly 50 million people
suffer from it, 5 million of them in the Region of the Americas . Nevertheless, it is estimated that over
50% of these people in Latin America and the Caribbean have no access to services. Furthe...
Mood disorders
Chapter E.3
2016 edition
The ICOPE guidance for person-centred assessment and pathways in primary care (ICOPE Handbook) helps community health and care workers put the recommendations outlined in the ICOPE Guidelines into practice. The Handbook assists with setting person-centred goals, screening for loss in a range of doma...
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua...
Accessed: 20.11.2019
This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline...
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
The framework sets out a response to current mental health challenges arising from the negative impact that the COVID-19 pandemic has had on population mental health and well-being. The EFAMH provides a coherent basis for intensified efforts to mainstream, promote and safeguard mental well-being as ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Specifically the Strategy focuses on five strategic objectives:
commitment to action on Healthy Ageing in every country;
developing age-friendly environments;
aligning health systems to the needs of older populations;
developing sustainable and equitable systems for providing lon...
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
